Evaluating construct and criterion validity of NeuroScreen in assessing neurocognition among hospitalized Ugandan first-episode psychosis patients

There was a moderate positive correlation between overall performance on both batteries. <i>NeuroScreen</i> shows promise as a valid assessment battery to assess neurocognition and detect NCI in FEP patients in Uganda. Further studies of <i>NeuroScreen</i> in healthy individuals and in a range of mental disorders are recommended.